Key Economic & Value Considerations for PDMPs in Europe
![](https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/647db267cdf8acb90fcb9376_PPTA%20Statement%20on%20Review%20of%20Donor%20Blood%20Pressure%20Requirements.webp)
PDMPs constitute several classes of biologic therapies, i.e. clotting factors, immunoglobulins (IgGs, including hyperimmune globulins), alpha-1 proteinase inhibitors, albumin and C1-esterase inhibitors. PDMPs share a unique nature: they are derived from human biologic material (plasma) and have a highly complex and regulated manufacturing process.